NovoCure
NVCR
NVCR
262 hedge funds and large institutions have $5.83B invested in NovoCure in 2019 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 80 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 240 → 262 (+22)
2.14% more ownership
Funds ownership: 68% → 70.14% (+2.1%)
3% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 80
Holders
262
Holding in Top 10
6
Calls
$65.1M
Puts
$54.6M
Top Buyers
| 1 | +$93.5M | |
| 2 | +$72.7M | |
| 3 | +$61.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$33.5M |
| 5 |
DCP
Darsana Capital Partners
New York
|
+$29.5M |
Top Sellers
| 1 | -$54.3M | |
| 2 | -$28.1M | |
| 3 | -$21.7M | |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$20.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$18.2M |